BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14748094)

  • 1. A decade of growth in public and private pharmaceutical expenditures: the case of Belgium 1990-1999.
    Vander Stichele RH; Peys F; Van Tielen R; Van Eeckhout H; van Essche O; Seys B
    Acta Clin Belg; 2003; 58(5):279-89; discussion 277-8. PubMed ID: 14748094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflation spurs health spending in 2000.
    Levit K; Smith C; Cowan C; Lazenby H; Martin A
    Health Aff (Millwood); 2002; 21(1):172-81. PubMed ID: 11900074
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved estimates of Belgian private health expenditure can give important lessons to other OECD countries.
    Calcoen P; Moens D; Verlinden P; van de Ven WP; Pacolet J
    Health Policy; 2015 Mar; 119(3):341-55. PubMed ID: 25108312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care spending growth: can we avoid fiscal Armageddon?
    Chernew M
    Inquiry; 2010-2011 Winter; 47(4):285-95. PubMed ID: 21391454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It's the prices, stupid: why the United States is so different from other countries.
    Anderson GF; Reinhardt UE; Hussey PS; Petrosyan V
    Health Aff (Millwood); 2003; 22(3):89-105. PubMed ID: 12757275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the distribution of health care financing across developed countries: the role of political economy of states.
    Calikoglu S
    Int J Health Serv; 2009; 39(1):59-83. PubMed ID: 19326779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health spending projections through 2013.
    Heffler S; Smith S; Keehan S; Clemens MK; Zezza M; Truffer C
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-79-93. PubMed ID: 15451969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants of the public-private mix in Canadian health care expenditures: 1975-1996.
    Di Matteo L
    Health Policy; 2000 Jun; 52(2):87-112. PubMed ID: 10794839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding Coverage of Oncology Drugs in an Aging, Upper-Middle-Income Country: Analyses of Public and Private Expenditures in Chile.
    Vargas V; Leopold C; Castillo-Riquelme M; Darrow JJ
    J Glob Oncol; 2019 Dec; 5():1-17. PubMed ID: 31860377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug spending trends for the privately insured in Maryland, 2000-2001.
    Shaya FT; Blume S; Mullins CD
    Health Aff (Millwood); 2004; 23(5):226-32. PubMed ID: 15371389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and expenditure at public and private facilities in 39 low-income countries.
    Saksena P; Xu K; Elovainio R; Perrot J
    Trop Med Int Health; 2012 Jan; 17(1):23-35. PubMed ID: 22008480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health care and out-of-pocket expenditures in Europe: results from the ESEMeD project.
    Sevilla-Dedieu C; Kovess-Masfety V; Gilbert F; Vilagut G; Koenig HH; Bruffaerts R; Haro JM; Alonso J
    J Ment Health Policy Econ; 2011 Jun; 14(2):95-105. PubMed ID: 21881165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket expenses for maternity care in rural Bangladesh: a public-private comparison.
    Rahman M; Rob U; Noor FR; Bellows B
    Int Q Community Health Educ; 2012-2013; 33(2):143-57. PubMed ID: 23661416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective.
    Petrou P
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):627-36. PubMed ID: 24953125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug expenditures of pensioners in 1997-2000].
    Swistak P; Błońska-Fajfrowska B
    Wiad Lek; 2003; 56(1-2):85-8. PubMed ID: 12901276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National health expenditures, 2002.
    Cowan C; Catlin A; Smith C; Sensenig A
    Health Care Financ Rev; 2004; 25(4):143-66. PubMed ID: 15493449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in drug utilization in Israel.
    Sax P
    Isr J Med Sci; 1992 Oct; 28(10):718-25. PubMed ID: 1399502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.